Nature Reviews Urology

Articles Available on Medscape

• The Epigenome as a Therapeutic Target in Prostate Cancer
  Prostate cancer has been proposed as a model of "epigenetic catastrophe." Widespread changes in DNA methylation patterns make prostate cancer an attractive disease for epigenetic drug targets.

  January 02, 2011

• Prostate Cancer: New Answers Prompt New Questions Regarding Cell of Origin
  Which cell type is involved in prostate cancer initiation?

  December 16, 2010

• Prostate Cancer: Patient-reported Functional Outcomes With Radiation Therapy
  This study provides information on health-related quality of life associated with high-dose radiation therapy for prostate cancer, which may assist physicians when counseling patients about treatment options.

  October 20, 2010

• mRCC stage Migration: Implications for Trial Design and Analysis
  Recruitment for patients enrolled in clinical trials for metastatic renal cell carcinoma may get more difficult, if current trends continue.

  July 02, 2010

• Trial Registration Cannot Alone Transform Scientific Conduct
  The relationship between trial registration and publication is not straightforward. Study protocol changes, omissions, and suppressions are the rule.

  January 29, 2010

More

Nature Reviews Urology's Latest Table of Contents

2011 - 8 (11)

• Male factor infertility: a relaxin effect on sperm parameters. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Surgery: Glutaraldehyde pretreatment prevents contraction of buccal mucosa grafts following urethroplasty. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• BPH: Saw palmetto extract no better than placebo for LUTS. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Prostate cancer: Abiraterone resistance mediated by CYP17A1 induction and androgen receptor splice variants. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Bladder cancer: Plant lectins have the potential to facilitate targeted delivery of intravesical chemotherapy agents. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Prostate cancer: who will win the CRPC drug race? 

  November 01, 2011

  • [ MEDLINE Abstract ]

• BPH: Perioperative advantages of laser treatment. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Surgery: is perinephric drainage essential after partial nephrectomy? 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Sexual dysfunction: MCID provides new perspective on erectile function research. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Urothelial carcinoma of the bladder: definition, treatment and future efforts. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Infection: prostate biopsy-infection and prior fluoroquinolone exposure. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Kidney cancer: treatment of clinically localized renal tumors in the elderly. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Prolactin regulation of the prostate gland: a female player in a male game. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Kidney cancer: long-term use of nonaspirin NSAIDs increases RCC risk. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Reactive oxygen species-mediated therapeutic control of bladder cancer. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Pediatrics: steroids can reduce renal scarring. 

  November 01, 2011

  • [ MEDLINE Abstract ]

• Testicular cancer: low gestational age increases risk. 

  November 01, 2011

  • [ MEDLINE Abstract ]